Journal article

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

J Proietto, A Rissanen, JB Harp, N Erondu, Q Yu, S Suryawanshi, ME Jones, AO Johnson-Levonas, SB Heymsfield, KD Kaufman, JM Amatruda

International Journal of Obesity | NATURE PUBLISHING GROUP | Published : 2010